5(S)-(2′-hydroxy ethoxy)-20(S)- camptothecin

Jonsson Comprehensive Cancer Center – Progressive Metastatic Castrate Resistant Prostate Cancer ArQule – PIK3CA-Related Overgrowth Spectrum (PROS) Wendell Yap, MD – Prostate Cancer Gerard Vockley, MD, PhD – Glucose Transporter 1 Deficiency Syndrome Impatients N.V. trading as myTomorrows – Graft Vs Host Disease MacroGenics – HER2-positive Breast Cancer Weill Medical College of Cornell University – Immunosuppression Reginald Dusing, MD – Prostate Cancer Xiaofan Zhu – Autosomal or Sex Linked Recessive Genetic Disease Pfizer – CD33 Positive Acute Myelogenous Leukemia Memorial Sloan Kettering Cancer Center – Recurrent Prostate Cancer Memorial Sloan Kettering Cancer Center – Prostate Cancer Zhejiang University – Stoma Closure Technic Novartis Pharmaceuticals – FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Atara Biotherapeutics – Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Jonsson Comprehensive Cancer Center – Prostate Cancer Loxo Oncology, Inc. – Neurotrophic Tyrosine Kinase, Receptor-related Proteins Astellas Pharma Global Development, Inc. – FMS-like Tyrosine Kinase-3 (FLT3) Mutations Eli Lilly and Company – Juvenile Dermatomyositis (JDM)